155 related articles for article (PubMed ID: 37037864)
21. OCT1 is a determinant of synbindin-related ERK signalling with independent prognostic significance in gastric cancer.
Qian J; Kong X; Deng N; Tan P; Chen H; Wang J; Li Z; Hu Y; Zou W; Xu J; Fang JY
Gut; 2015 Jan; 64(1):37-48. PubMed ID: 24717932
[TBL] [Abstract][Full Text] [Related]
22. RIPK4/PEBP1 axis promotes pancreatic cancer cell migration and invasion by activating RAF1/MEK/ERK signaling.
Qi ZH; Xu HX; Zhang SR; Xu JZ; Li S; Gao HL; Jin W; Wang WQ; Wu CT; Ni QX; Yu XJ; Liu L
Int J Oncol; 2018 Apr; 52(4):1105-1116. PubMed ID: 29436617
[TBL] [Abstract][Full Text] [Related]
23. Psoriasin overexpression confers drug resistance to cisplatin by activating ERK in gastric cancer.
Li L; Cui Y; Ye L; Zhao Z; Jiang WG; Ji J
Int J Oncol; 2018 Sep; 53(3):1171-1182. PubMed ID: 29956751
[TBL] [Abstract][Full Text] [Related]
24. MAWBP and MAWD inhibit proliferation and invasion in gastric cancer.
Li DM; Zhang J; Li WM; Cui JT; Pan YM; Liu SQ; Xing R; Lu YY
World J Gastroenterol; 2013 May; 19(18):2781-92. PubMed ID: 23687415
[TBL] [Abstract][Full Text] [Related]
25. CircDNAJC11 interacts with TAF15 to promote breast cancer progression via enhancing MAPK6 expression and activating the MAPK signaling pathway.
Wang B; Chen H; Deng Y; Chen H; Xing L; Guo Y; Wang M; Chen J
J Transl Med; 2023 Mar; 21(1):186. PubMed ID: 36895010
[TBL] [Abstract][Full Text] [Related]
26. PHD2 acts as an oncogene through activation of Ras/Raf/MEK/ERK and JAK1/STAT3 pathways in human hepatocellular carcinoma cells.
Guo J; Lan Z
Artif Cells Nanomed Biotechnol; 2020 Dec; 48(1):37-45. PubMed ID: 31852247
[No Abstract] [Full Text] [Related]
27. Nitric oxide-mediated promotion of mammary tumour cell migration requires sequential activation of nitric oxide synthase, guanylate cyclase and mitogen-activated protein kinase.
Jadeski LC; Chakraborty C; Lala PK
Int J Cancer; 2003 Sep; 106(4):496-504. PubMed ID: 12845643
[TBL] [Abstract][Full Text] [Related]
28. DC-SIGN mediates gastric cancer progression by regulating the JAK2/STAT3 signaling pathway and affecting LncRNA RP11-181G12.2 expression.
Li X; Na H; Xu L; Zhang X; Feng Z; Zhou X; Cui J; Zhang J; Lin F; Yang S; Yue F; Mousa H; Zuo Y
Biomed Pharmacother; 2020 Jan; 121():109644. PubMed ID: 31766099
[TBL] [Abstract][Full Text] [Related]
29. ERK1/2 signalling pathway is involved in CD147-mediated gastric cancer cell line SGC7901 proliferation and invasion.
Chen L; Pan Y; Gu L; Nie Z; He B; Song G; Li R; Xu Y; Gao T; Wang S
Exp Biol Med (Maywood); 2013 Aug; 238(8):903-12. PubMed ID: 23828593
[TBL] [Abstract][Full Text] [Related]
30. miR-4510 blocks hepatocellular carcinoma development through RAF1 targeting and RAS/RAF/MEK/ERK signalling inactivation.
Ghousein A; Mosca N; Cartier F; Charpentier J; Dupuy JW; Raymond AA; Bioulac-Sage P; Grosset CF
Liver Int; 2020 Jan; 40(1):240-251. PubMed ID: 31612616
[TBL] [Abstract][Full Text] [Related]
31. MiR-592 Promotes Gastric Cancer Proliferation, Migration, and Invasion Through the PI3K/AKT and MAPK/ERK Signaling Pathways by Targeting Spry2.
He Y; Ge Y; Jiang M; Zhou J; Luo D; Fan H; Shi L; Lin L; Yang L
Cell Physiol Biochem; 2018; 47(4):1465-1481. PubMed ID: 29949784
[TBL] [Abstract][Full Text] [Related]
32. hsa_circ_001653 up-regulates NR6A1 expression and elicits gastric cancer progression by binding to microRNA-377.
Zhou W; Jiang R; Wang Y; Li Y; Sun Z; Zhao H
Exp Physiol; 2020 Dec; 105(12):2141-2153. PubMed ID: 33006200
[TBL] [Abstract][Full Text] [Related]
33. Decreased expression of miR-939 contributes to chemoresistance and metastasis of gastric cancer via dysregulation of SLC34A2 and Raf/MEK/ERK pathway.
Zhang JX; Xu Y; Gao Y; Chen C; Zheng ZS; Yun M; Weng HW; Xie D; Ye S
Mol Cancer; 2017 Jan; 16(1):18. PubMed ID: 28114937
[TBL] [Abstract][Full Text] [Related]
34. Histone deacetylase 1 promotes glioblastoma cell proliferation and invasion via activation of PI3K/AKT and MEK/ERK signaling pathways.
Li S; Chen X; Mao L; Zahid KR; Wen J; Zhang L; Zhang M; Duan J; Duan J; Yin X; Wang Y; Zhao L; Tang X; Wang X; Xu G
Brain Res; 2018 Aug; 1692():154-162. PubMed ID: 29782850
[TBL] [Abstract][Full Text] [Related]
35. Long non-coding RNA LINC01225 promotes proliferation, invasion and migration of gastric cancer via Wnt/β-catenin signalling pathway.
Xu Y; Zhang G; Zou C; Qi W; Gong Z; Zhang G; Ma G; Zhang W; Jiang P
J Cell Mol Med; 2019 Nov; 23(11):7581-7591. PubMed ID: 31460694
[TBL] [Abstract][Full Text] [Related]
36. CSE1L silence inhibits the growth and metastasis in gastric cancer by repressing GPNMB via positively regulating transcription factor MITF.
Li Y; Yuan S; Liu J; Wang Y; Zhang Y; Chen X; Si W
J Cell Physiol; 2020 Mar; 235(3):2071-2079. PubMed ID: 31347172
[TBL] [Abstract][Full Text] [Related]
37. CD97 promotes gastric cancer cell proliferation and invasion through exosome-mediated MAPK signaling pathway.
Li C; Liu DR; Li GG; Wang HH; Li XW; Zhang W; Wu YL; Chen L
World J Gastroenterol; 2015 May; 21(20):6215-28. PubMed ID: 26034356
[TBL] [Abstract][Full Text] [Related]
38. microRNA-33a prevents epithelial-mesenchymal transition, invasion, and metastasis of gastric cancer cells through the Snail/Slug pathway.
Chen DD; Cheng JT; Chandoo A; Sun XW; Zhang L; Lu MD; Sun WJ; Huang YP
Am J Physiol Gastrointest Liver Physiol; 2019 Aug; 317(2):G147-G160. PubMed ID: 30943047
[TBL] [Abstract][Full Text] [Related]
39. Lysyl oxidase-like 4 (LOXL4) promotes proliferation and metastasis of gastric cancer via FAK/Src pathway.
Li RK; Zhao WY; Fang F; Zhuang C; Zhang XX; Yang XM; Jiang SH; Kong FZ; Tu L; Zhang WM; Yang SL; Cao H; Zhang ZG
J Cancer Res Clin Oncol; 2015 Feb; 141(2):269-81. PubMed ID: 25216702
[TBL] [Abstract][Full Text] [Related]
40. Targeting of SPP1 by microRNA-340 inhibits gastric cancer cell epithelial-mesenchymal transition through inhibition of the PI3K/AKT signaling pathway.
Song SZ; Lin S; Liu JN; Zhang MB; Du YT; Zhang DD; Xu WH; Wang HB
J Cell Physiol; 2019 Aug; 234(10):18587-18601. PubMed ID: 30953349
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
